文献速递术前评估与围术期医学气道管理

琥珀胆碱与术后肺部并发症:基于两家医院网络登记数据的回顾性队列研究

Succinylcholine and postoperative pulmonary complications: a retrospective cohort study using registry data from two hospital networks.
PubMed 文献 · Br J Anaesth · 2020-07-10

琥珀胆碱使用与POPC风险增加相关(校正OR=1.11,95%CI 1.06-1.16,P<0.001),呈剂量依赖性,且手术时间<2小时者关联更强。

要点

  • 琥珀胆碱使用与术后肺部并发症风险增加独立相关,校正OR=1.11。
  • 风险呈剂量依赖性,每增加1 mg/kg,校正OR=1.08。
  • 手术时间<2小时者关联更强(校正OR=1.24),≥2小时者为1.05。

核心结论

  • 琥珀胆碱使用与术后肺部并发症风险增加相关,呈剂量依赖性,且在短手术中关联更强。

主要发现

  • 琥珀胆碱使用与POPC风险增加相关(校正OR=1.11;95%CI 1.06-1.16;P<0.001)。
  • 校正风险:未用琥珀胆碱为5.18%(95%CI 5.06-5.30),使用为5.69%(95%CI 5.53-5.85)。
  • 剂量依赖性关系:每mg/kg校正OR=1.08(95%CI 1.05-1.11;P<0.001)。
  • 在非去极化NMBA使用者中,琥珀胆碱进一步增加POPC风险(校正OR=1.08;95%CI 1.03-1.14;P=0.001)。

关键数值与推荐

  • POPC定义为拔管后血红蛋白氧饱和度<90%或术后7天内需ICU再插管。

临床怎么用

  • 麻醉科医生应权衡琥珀胆碱使用,尤其短手术中,关注术后肺部并发症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuromuscular blocking agents (NMBAs) with a non-depolarising mechanism of action carry the risk of postoperative residual paralysis and are associated with postoperative pulmonary complications (POPC). Owing to the shorter duration of action, the depolarising NMBA succinylcholine may be associated with less postoperative residual paralysis, and hence fewer POPC. We tested the association of succinylcholine administration during anaesthesia and POPC. METHODS: In a retrospective cohort study of registry data from two large US academic medical centres, 244 850 adult noncardiac surgical patients undergoing general anaesthesia were included. The primary outcome was POPC, defined as post-extubation haemoglobin oxygen de-saturation to <90%, or re-intubation requiring intensive care unit admission within 7 days after surgery. The association between succinylcholine and POPC and its dose-dependency were tested in a hierarchical fashion using a multivariable logistic regression model. RESULTS: A total of 13 206 patients (5.4%) experienced POPC. Use of succinylcholine was associated with increased risk of POPC (adjusted odds ratio [ORAdj]=1.11; 95% confidence interval [CI], 1.06-1.16; P<0.001; adjusted risk=5.18%; 95% CI, 5.06-5.30 without and 5.69%; 95% CI, 5.53-5.85 with succinylcholine), with a dose-dependent relationship (ORAdj=1.08; 95% CI, 1.05-1.11 per mg kg-1; P<0.001). In patients receiving non-depolarising NMBAs, succinylcholine further increased the risk of POPC (ORAdj=1.08; 95% CI, 1.03-1.14; P=0.001). The association between succinylcholine and POPC was modified (P=0.03 for interaction) by the duration of surgery with higher odds of POPC in patients undergoing surgeries of <2 vs ≥2 h (ORAdj=1.24; 95% CI, 1.15-1.33 and 1.05; 95% CI, 1.00-1.10, respectively). CONCLUSIONS: In contrast to our prediction, succinylcholine administration was associated with an increased risk of POPC. This association was dose-dependent and magnified in surgeries of shorter duration.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Schaefer MS, Hammer M, Santer P, et al. Succinylcholine and postoperative pulmonary complications: a retrospective cohort study using registry data from two hospital networks. Br J Anaesth. 2020. PMID: 32654742. doi:10.1016/j.bja.2020.05.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。